BioBridgeXAll companies

Crimson BioPharm Inc.

Biotechnology company · Brookline, Massachusetts, United States

Crimson BioPharm Inc. is a biotechnology company headquartered in Brookline, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $400,000 in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2019.

Profile compiled from public records. Is this your company? Request a correction or update

Crimson BioPharm at a glance

Typebiotechnology company
HeadquartersBrookline, Massachusetts, United States
Earliest incorporation on record2018
Employees (self-reported, 2023)5
SEC CIK1791173

What does Crimson BioPharm do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $400,000 in total (2023). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $1 million sold (2019).

Frequently asked questions about Crimson BioPharm

Where is Crimson BioPharm headquartered?

Crimson BioPharm Inc. is headquartered in Brookline, Massachusetts, United States.

What does Crimson BioPharm do?

Crimson BioPharm Inc. is a biotechnology company.

When was Crimson BioPharm founded?

The earliest incorporation on record for Crimson BioPharm Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences